Hiccup secondary to dopamine agonists in Parkinson's disease [1]

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1667-1668

  Lester, Jacobo ^a   Raina, Gabriela Beatriz ^b   Uribe Roca, Claudia ^b   Micheli, Federico ^b  

^a HOSPITAL ÁNGELES LOMAS   (Mexico)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; PIRIBEDIL; PRAMIPEXOLE; SELEGILINE;

ACUTE HEART INFARCTION; AGED; BRADYKINESIA; CASE REPORT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HICCUP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; TREMOR;

AGED; DOPAMINE AGONISTS; HICCUP; HUMANS; MALE; PARKINSON DISEASE;

EID: 34748828186     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21583     Document Type: Letter

References (8)

1. Kahrilas PJ, Shi G. Why do we hiccup? Gut 1997;41:712-713.
2. Bagheri H, Cismondo S, Montastruc JL. Drug-induced hiccup: a review of the France pharmacologic vigilance database. Therapie 1999;54:35-39.
3. Sharma P, Morgan JC, Sethi KD. Hiccups associated with dopamine agonists in Parkinson disease. Neurology 2006;66:774.
4. Martínez-Ruíz M, Fernández RFA, Quesada RR. Pramipexole for intractable hiccups. Med Clin (Barc) 2004;123:679.
5. Miyaoka H, Kamijima K. Perphenazine-induced hiccups. Pharmacopsychiatry 1999;32:81.
6. Perachon S, Schwartz JC, Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur J Pharmacol 1999;366:293-300.
7. a edición. Buenos Aires, Argentina: editorial médica Panamericana; 2006. p 47-73.
8. Kumar A, Dromerick AW. Intractable hiccups during stroke rehabilitation. Arch Phys Med Rehabil 1998;79:697-699.